CDK6 (Cyclin-Dependent Kinase 6) encodes a serine/threonine kinase that partners with D-type cyclins (CCND1, CCND2, CCND3) to form active kinase complexes that drive cell cycle progression from G1 to S phase["@sherr1999"]. Beyond cell cycle regulation, CDK6 has important non-cyclin-dependent functions in neuronal differentiation, synaptic plasticity, and DNA damage response["@malumbres2009"]. CDK6 is increasingly recognized for its roles in neurodegeneration and its potential as a therapeutic target.
Function
The CDK6 gene encodes Cyclin-Dependent Kinase 6, a 326-amino acid serine/threonine kinase:
Cell Cycle G1/S Transition: Phosphorylates retinoblastoma protein (Rb), releasing E2F transcription factors to activate S-phase genes[@lim2013].
Cellular Differentiation: Regulates differentiation of various cell types including [neurons](/entities/neurons), osteoblasts, and adipocytes.
Transcriptional Regulation: Controls gene expression through phosphorylation of transcription factors and chromatin modifiers.
DNA Damage Response: Involved in DNA damage checkpoints and repair.
Synaptic Plasticity: Regulates synaptic protein synthesis and dendritic spine morphology.
[Autophagy](/entities/autophagy): Modulates autophagy through phosphorylation of autophagy-related proteins.
Disease Associations
Cancer: Oncogenic driver in many cancers; CDK6 is frequently amplified or overexpressed in gliomas, lymphomas, and carcinomas. Multiple CDK4/6 inhibitors approved for breast cancer.
Alzheimer's Disease: CDK6 activity is elevated in AD brain; promotes [tau](/proteins/tau) phosphorylation and [amyloid-beta](/proteins/amyloid-beta) production. CDK6 inhibitors show neuroprotective effects in models.
Parkinson's Disease: CDK6 contributes to dopaminergic neuron death through regulation of [α-synuclein](/proteins/alpha-synuclein) expression and mitochondrial dysfunction.
Amyotrophic Lateral Sclerosis: Altered CDK6 activity in motor neurons; potential therapeutic target.
Glioma: Oncogenic role through cell cycle dysregulation and altered differentiation.
Expression
CDK6 is widely expressed in proliferating cells with highest expression in embryonic tissues and certain adult tissues including brain, bone marrow, and thymus. In the brain, CDK6 is expressed in neurons and glial cells. Expression is regulated by growth factors, cellular stress, and developmental signals. In neurodegenerative diseases, CDK6 expression is often upregulated in affected brain regions.
Background
The study of Cdk6 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Key Publications
CCND1 Gene - D-type cyclin partner
Cell Cycle - G1/S transition
Tau Phosphorylation - Alzheimer's disease mechanism